184 related articles for article (PubMed ID: 31455838)
1. Multi-study reanalysis of 2,213 acute myeloid leukemia patients reveals age- and sex-dependent gene expression signatures.
Roushangar R; Mias GI
Sci Rep; 2019 Aug; 9(1):12413. PubMed ID: 31455838
[TBL] [Abstract][Full Text] [Related]
2. Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia.
Rao AV; Valk PJ; Metzeler KH; Acharya CR; Tuchman SA; Stevenson MM; Rizzieri DA; Delwel R; Buske C; Bohlander SK; Potti A; Löwenberg B
J Clin Oncol; 2009 Nov; 27(33):5580-6. PubMed ID: 19858393
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.
Handschuh L; Kaźmierczak M; Milewski MC; Góralski M; Łuczak M; Wojtaszewska M; Uszczyńska-Ratajczak B; Lewandowski K; Komarnicki M; Figlerowicz M
Int J Oncol; 2018 Mar; 52(3):656-678. PubMed ID: 29286103
[TBL] [Abstract][Full Text] [Related]
4. Low SMC1A protein expression predicts poor survival in acute myeloid leukemia.
Hömme C; Krug U; Tidow N; Schulte B; Kühler G; Serve H; Bürger H; Berdel WE; Dugas M; Heinecke A; Büchner T; Koschmieder S; Müller-Tidow C
Oncol Rep; 2010 Jul; 24(1):47-56. PubMed ID: 20514443
[TBL] [Abstract][Full Text] [Related]
5. Systematic computation with functional gene-sets among leukemic and hematopoietic stem cells reveals a favorable prognostic signature for acute myeloid leukemia.
Yang XH; Li M; Wang B; Zhu W; Desgardin A; Onel K; de Jong J; Chen J; Chen L; Cunningham JM
BMC Bioinformatics; 2015 Mar; 16():97. PubMed ID: 25887548
[TBL] [Abstract][Full Text] [Related]
6. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
Haouas H; Haouas S; Uzan G; Hafsia A
Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
[TBL] [Abstract][Full Text] [Related]
7. [Evolution of gene expression profile in 3 cases of acute myeloid leukemia].
Tang JM; Meng FY; Ma WL
Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):653-5. PubMed ID: 16620549
[TBL] [Abstract][Full Text] [Related]
8. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J
J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328
[TBL] [Abstract][Full Text] [Related]
9. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
Shi JL; Fu L; Wang WD
Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
[TBL] [Abstract][Full Text] [Related]
10. Expression profile analysis of long non-coding RNA in acute myeloid leukemia by microarray and bioinformatics.
Feng Y; Shen Y; Chen H; Wang X; Zhang R; Peng Y; Lei X; Liu T; Liu J; Gu L; Wang F; Yang Y; Bai J; Wang J; Zhao W; He A
Cancer Sci; 2018 Feb; 109(2):340-353. PubMed ID: 29220122
[TBL] [Abstract][Full Text] [Related]
11. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.
Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R
Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458
[TBL] [Abstract][Full Text] [Related]
12. Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia.
Jamalpour M; Li X; Cavelier L; Gustafsson K; Mostoslavsky G; Höglund M; Welsh M
Tumour Biol; 2017 Oct; 39(10):1010428317720643. PubMed ID: 28982308
[TBL] [Abstract][Full Text] [Related]
13. In Silico Methods for the Identification of Diagnostic and Favorable Prognostic Markers in Acute Myeloid Leukemia.
Yılmaz H; Toy HI; Marquardt S; Karakülah G; Küçük C; Kontou PI; Logotheti S; Pavlopoulou A
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502522
[TBL] [Abstract][Full Text] [Related]
14. A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects.
Wouters BJ; Löwenberg B; Delwel R
Blood; 2009 Jan; 113(2):291-8. PubMed ID: 18703705
[TBL] [Abstract][Full Text] [Related]
15. Identification of a robust subpathway-based signature for acute myeloid leukemia prognosis using an miRNA integrated strategy.
Chang H; Gao Q; Ding W; Qing X
PLoS One; 2018; 13(3):e0194245. PubMed ID: 29570744
[TBL] [Abstract][Full Text] [Related]
16. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
17. Identification of gene expression signatures for molecular classification in human leukemia cells.
Song JH; Kim HJ; Lee CH; Kim SJ; Hwang SY; Kim TS
Int J Oncol; 2006 Jul; 29(1):57-64. PubMed ID: 16773185
[TBL] [Abstract][Full Text] [Related]
18. Gene expression microarray public dataset reanalysis in chronic obstructive pulmonary disease.
Rogers LRK; Verlinde M; Mias GI
PLoS One; 2019; 14(11):e0224750. PubMed ID: 31730674
[TBL] [Abstract][Full Text] [Related]
19. A novel scoring system for acute myeloid leukemia risk assessment based on the expression levels of six genes.
Zhao X; Li Y; Wu H
Int J Mol Med; 2018 Sep; 42(3):1495-1507. PubMed ID: 29956722
[TBL] [Abstract][Full Text] [Related]
20. BEX1 acts as a tumor suppressor in acute myeloid leukemia.
Lindblad O; Li T; Su X; Sun J; Kabir NN; Levander F; Zhao H; Lu G; Rönnstrand L; Kazi JU
Oncotarget; 2015 Aug; 6(25):21395-405. PubMed ID: 26046670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]